LNG Patch

Alternative Name: Levonorgestrel (LNG)-only patch; AG890

Description: A low-dose, progestin-only contraceptive patch. It has been tested at two doses: 75mg/day and 40mg/day.

Product Details

User: Female

Hormonal: Yes

Delivery Method: Transdermal

Duration Type: Short-acting

Duration: One week

Regimen:
  • Replaced every 7 days in a continuous 28-day regimen with no patch-free interval

Dose: 75mg/day or 40mg/day

Active Pharmaceutical Ingredient (API):
  • levonorgestrel

Multipurpose Preventive Technology (MPT): No

Status Details

Developer: Agile Therapeutics

Project Phase: Pre-Clinical and Clinical Development

Development Stage: Phase II

Active Development: Yes

Status Details:
  • Phase II study to evaluate pharmacokinetics and safety has been completed.

Additional Information

References:
  • Agile Therapeutics website: https://www.agiletherapeutics.com

  • Clinicaltrials.gov Identified NCT01623466

  • Westhoff CL, et al. (2018) Phase I/II pharmacokinetic and pharmacodynamic evaluation of two levonorgestrel-only contraceptive patches in a multicenter randomized trial. Contraception. 98(2);151-157.

Vertical Tabs

Print